EA201590698A1 - Жидкофазные способы получения макроциклических депсипептидов и новые промежуточные соединения - Google Patents
Жидкофазные способы получения макроциклических депсипептидов и новые промежуточные соединенияInfo
- Publication number
- EA201590698A1 EA201590698A1 EA201590698A EA201590698A EA201590698A1 EA 201590698 A1 EA201590698 A1 EA 201590698A1 EA 201590698 A EA201590698 A EA 201590698A EA 201590698 A EA201590698 A EA 201590698A EA 201590698 A1 EA201590698 A1 EA 201590698A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- dipsypeps
- liquid
- new intermediate
- phase methods
- intermediate connections
- Prior art date
Links
- 239000007791 liquid phase Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 108010002156 Depsipeptides Proteins 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/74—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K11/02—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0819—Tripeptides with the first amino acid being acidic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261711284P | 2012-10-09 | 2012-10-09 | |
| PCT/IB2013/059196 WO2014057418A2 (en) | 2012-10-09 | 2013-10-08 | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201590698A1 true EA201590698A1 (ru) | 2015-07-30 |
Family
ID=49880854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201590698A EA201590698A1 (ru) | 2012-10-09 | 2013-10-08 | Жидкофазные способы получения макроциклических депсипептидов и новые промежуточные соединения |
Country Status (14)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103298827B (zh) | 2007-08-17 | 2017-05-31 | 诺华股份有限公司 | 环状酯肽 |
| US8680054B2 (en) | 2011-04-20 | 2014-03-25 | Novartis Ag | Suspension type topical formulations comprising cyclic depsipeptide |
| US8614289B2 (en) | 2011-04-20 | 2013-12-24 | Novartis Ag | Processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US8987413B2 (en) | 2012-10-09 | 2015-03-24 | Novartis Ag | Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US9067978B2 (en) | 2012-10-09 | 2015-06-30 | Novartis Ag | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US10947267B2 (en) | 2015-12-21 | 2021-03-16 | Texas Tech University System | System and method for solution phase gap peptide synthesis |
| WO2019217116A1 (en) * | 2018-05-06 | 2019-11-14 | Gap Peptides Llc | Method for solution-phase peptide synthesis |
| US12024537B2 (en) | 2018-05-31 | 2024-07-02 | Sederma | Compositions and methods for chemical synthesis |
| WO2020018888A1 (en) | 2018-07-20 | 2020-01-23 | The Board Of Regents Of The University Of Oklahoma | Antimicrobial peptides and methods of use |
| EP3917937A4 (en) | 2019-02-01 | 2022-11-23 | Sederma | SYNTHETIC STRATEGY FOR A SPLIT PROTECTION GROUP |
| JP7162853B1 (ja) * | 2021-07-02 | 2022-10-31 | ペプチスター株式会社 | 液相ペプチド合成用担体結合ペプチドの分析方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3043252C2 (de) | 1980-11-15 | 1982-12-02 | Degussa Ag, 6000 Frankfurt | Cyclische Acetale von N-Acylglutaminsäure -γ- semialdehyden, Verfahren zu deren Herstellung und ihre Verwendung |
| US5595756A (en) | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
| DE4421113A1 (de) | 1994-06-16 | 1995-12-21 | Biotechnolog Forschung Gmbh | Chondramide, Gewinnungsverfahren, Mittel mit Chondramiden und Mischkultur zur Chondramid-Gewinnung |
| DE19828043A1 (de) | 1998-06-24 | 1999-12-30 | Bayer Ag | Ektoparasitizide Mittel |
| JP2000154198A (ja) | 1998-11-20 | 2000-06-06 | Nisshin Flour Milling Co Ltd | 環状デプシペプチドの固相合成方法及びその中間体 |
| GB0108234D0 (en) | 2001-04-02 | 2001-05-23 | Pharma Mar Sa | Process for producing trunkamide A compounds |
| US20040110228A1 (en) | 2002-04-01 | 2004-06-10 | Mcalpine Shelli R. | Combinatorial organic synthesis of unique biologically active compounds |
| PL1631295T3 (pl) | 2003-06-06 | 2010-09-30 | Arexis Ab | Zastosowanie skondensowanych związków heterocyklicznych jako inhibitorów SCCE do leczenia chorób skóry |
| GB0322140D0 (en) | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
| EP1716248A1 (en) | 2004-02-03 | 2006-11-02 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with kallikrein 7 (klk7) |
| JP2009532664A (ja) | 2006-02-27 | 2009-09-10 | アリゾナ・ボード・オブ・リージェンツ・フォー・アンド・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティ | 癌の治療のためのノボペプチドの同定および使用 |
| GB0715750D0 (en) | 2007-08-13 | 2007-09-19 | Karus Therapeutics Ltd | Chemical compounds |
| CN103298827B (zh) * | 2007-08-17 | 2017-05-31 | 诺华股份有限公司 | 环状酯肽 |
| ES2527298T3 (es) | 2007-08-17 | 2015-01-22 | Novartis Ag | Uso de depsipéptidos cíclicos para inhibir calicreína 7 |
| DE102007052391A1 (de) | 2007-10-31 | 2009-05-07 | Henkel Ag & Co. Kgaa | Mattwachs |
| US20110112121A1 (en) | 2009-07-06 | 2011-05-12 | Joerg Berghausen | Pharmaceutical Compositions and Solid Forms |
| US20120064013A1 (en) | 2010-02-03 | 2012-03-15 | David Marcos | Foamable topical composition |
| KR101004362B1 (ko) | 2010-03-19 | 2010-12-28 | 가톨릭대학교 산학협력단 | 자가 면역 질환 예방 및 치료용 ＴＮＦ－α와 ＴＷＥＡＫ 이중 길항제 |
| US20120064136A1 (en) | 2010-09-10 | 2012-03-15 | Nanobio Corporation | Anti-aging and wrinkle treatment methods using nanoemulsion compositions |
| KR20240119180A (ko) | 2011-01-24 | 2024-08-06 | 안테리오스, 인코퍼레이티드 | 나노입자 조성물, 이의 제형, 및 그의 용도 |
| DK2667854T3 (en) | 2011-01-24 | 2019-04-23 | Anterios Inc | NANO PARTICLE FORMATIONS |
| US8680054B2 (en) | 2011-04-20 | 2014-03-25 | Novartis Ag | Suspension type topical formulations comprising cyclic depsipeptide |
| US8614289B2 (en) | 2011-04-20 | 2013-12-24 | Novartis Ag | Processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US8987413B2 (en) | 2012-10-09 | 2015-03-24 | Novartis Ag | Aldehyde acetal based processes for the manufacture of macrocyclic depsipeptides and new intermediates |
| US9067978B2 (en) | 2012-10-09 | 2015-06-30 | Novartis Ag | Solution phase processes for the manufacture of macrocyclic depsipeptides and new intermediates |
-
2013
- 2013-10-04 US US14/045,844 patent/US9067978B2/en active Active
- 2013-10-08 AU AU2013328284A patent/AU2013328284B2/en not_active Ceased
- 2013-10-08 TW TW102136392A patent/TW201418278A/zh unknown
- 2013-10-08 KR KR1020157008834A patent/KR20150065709A/ko not_active Withdrawn
- 2013-10-08 CA CA2884393A patent/CA2884393A1/en not_active Abandoned
- 2013-10-08 JP JP2015536260A patent/JP2015533156A/ja active Pending
- 2013-10-08 EP EP13812092.8A patent/EP2906585A2/en not_active Withdrawn
- 2013-10-08 CN CN201380051965.7A patent/CN104703997A/zh active Pending
- 2013-10-08 WO PCT/IB2013/059196 patent/WO2014057418A2/en active Application Filing
- 2013-10-08 IN IN1811DEN2015 patent/IN2015DN01811A/en unknown
- 2013-10-08 MX MX2015004629A patent/MX2015004629A/es unknown
- 2013-10-08 EA EA201590698A patent/EA201590698A1/ru unknown
- 2013-10-08 BR BR112015007196A patent/BR112015007196A2/pt not_active IP Right Cessation
- 2013-10-09 AR ARP130103654A patent/AR092948A1/es unknown
-
2015
- 2015-04-15 US US14/686,899 patent/US9493512B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| IN2015DN01811A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-05-29 |
| US9493512B2 (en) | 2016-11-15 |
| KR20150065709A (ko) | 2015-06-15 |
| EP2906585A2 (en) | 2015-08-19 |
| CA2884393A1 (en) | 2014-04-17 |
| US20150218224A1 (en) | 2015-08-06 |
| US9067978B2 (en) | 2015-06-30 |
| AU2013328284B2 (en) | 2016-07-14 |
| BR112015007196A2 (pt) | 2017-07-04 |
| JP2015533156A (ja) | 2015-11-19 |
| AU2013328284A1 (en) | 2015-03-12 |
| US20140100355A1 (en) | 2014-04-10 |
| WO2014057418A2 (en) | 2014-04-17 |
| AR092948A1 (es) | 2015-05-06 |
| CN104703997A (zh) | 2015-06-10 |
| TW201418278A (zh) | 2014-05-16 |
| MX2015004629A (es) | 2015-07-14 |
| WO2014057418A3 (en) | 2014-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201590698A1 (ru) | Жидкофазные способы получения макроциклических депсипептидов и новые промежуточные соединения | |
| CY1123958T1 (el) | Μεθοδος παρασκευης παραγωγων και ενδιαμεσων καρβαμοϋλπυριδονης | |
| EA201490474A1 (ru) | Аминохиназолины в качестве ингибиторов киназ | |
| EA201491811A1 (ru) | АНТИ-LgR5 АНТИТЕЛА И ИММУНОКОНЪЮГАТЫ | |
| EA202092987A3 (ru) | Липид, содержащий докозапентаеновую кислоту | |
| EA201391274A1 (ru) | Аминохинолины в качестве ингибиторов киназ | |
| EA201590718A1 (ru) | Способы получения макроциклических депсипептидов с использованием ацетальальдегида и новые промежуточные соединения | |
| EA201891264A3 (ru) | Антагонисты st2l и способы их применения | |
| CO7141403A2 (es) | Procesos para producir ciertos 2 (piridin 3 il)tiazoles | |
| CO7141404A2 (es) | Procesos para producir ciertos 2 (piridin 3 il)tiazoles | |
| EA201491947A1 (ru) | Антитела и иммуноконъюгаты к ly6e и способы применения | |
| EA201890333A1 (ru) | Противовирусные соединения | |
| EA201391554A1 (ru) | Способы получения макроциклических депсипептидов и новых промежуточных соединений | |
| EA201391180A1 (ru) | Способ получения оптически активных производных дигидробензофурана | |
| EP2852671A4 (en) | GENERATION OF HUMAN IPS CELLS BY SYNTHETIC SELF-REPLICATIVE RNA | |
| EA201391389A1 (ru) | Кристаллы антител против склеростина и составы на их основе | |
| UY33931A (es) | Agentes de union biespecificos | |
| UA111827C2 (uk) | Спосіб отримання інгенол-3-ангелату | |
| UA110813C2 (uk) | Лікування ліподистрофії | |
| EA201490850A1 (ru) | Состав антитела, пригодный для профилактики и лечения амилоидоза, его варианты и способ его получения | |
| EA201690520A1 (ru) | Способ получения замещенных 5-фтор-1h-пиразолопиридинов | |
| EA201691141A1 (ru) | Соединения против ccr6 | |
| EA201300443A1 (ru) | Способ получения дигидроптеридинонов и их промежуточных продуктов | |
| EA201390467A1 (ru) | Композиции антител и способы применения | |
| EA201491278A1 (ru) | Модифицированный коллаген |